Decision spine
Frames the controlling thesis, evidence status, buyer implications, and research-use limits.
Emerging Med Tech
Zemi Dossier
Research-use only
Organ-on-Chip / NAM Qualification
A decision package on when organ-on-chip and new approach methodology systems are qualified for a context of use rather than merely biologically impressive.
Decision this dossier helps answer
Which context of use is the chip actually qualified to support, and what reproducibility or anchor-transfer evidence is still missing?
Problem this dossier solves
Context comes before chip complexity.
The dossier argues that organ-on-chip value is governed by qualification discipline: reproducibility, anchor transfer, context of use, and decision relevance. More biology only matters if it improves the specific decision the model is meant to support.
What is moving: current field evidence and platform activity
What is unresolved: decision-grade proof, endpoint logic, and failure modes
What Zemi solves: evidence-gated next-study strategy
Full decision package
123-page research report plus 32-sheet Evidence & Decision Workbook
Buy now
$3,500$5,500Launch price
Controlling thesis
Context comes before chip complexity.
The dossier argues that organ-on-chip value is governed by qualification discipline: reproducibility, anchor transfer, context of use, and decision relevance. More biology only matters if it improves the specific decision the model is meant to support.
A Zemi Dossier turns uncertain emerging research into a decision package: what is known, what is inferred, what is hypothetical, what would falsify the thesis, and what should be built, funded, avoided, monitored, or validated next.
Research report preview
First 30 pages of the actual Organ-on-Chip / NAM Qualification research report.
The public page shows the real document style, density, evidence posture, and decision framing before a buyer requests access to the full Zemi Dossier package.
Research report
The research report is the argument. It is not the whole product.
The PDF research report is the structured argument: field status, evidence maturity, buyer implications, falsifiable hypotheses, power-calculated next studies, strategic recommendations, limitations, and traceability posture.
Inspectable infrastructure
Pairs the report with claim ledgers, evidence tables, power rows, audit surfaces, and decision tools.
Executable next studies
Links hypotheses to endpoint logic, assumptions, sample-size logic, budget, and timeline planning.
Research report table of contents
Public TOC generated from the source report.
The full research report is delivered as a licensed PDF. This table shows the decision structure without publishing the full product.
| Section | What it covers | Buyer value |
|---|---|---|
| Decision Brief Read This First | Turns the report into immediate buyer triage: what matters now, what is still uncertain, and what to do next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Contents | Shows the report structure and where to inspect the argument, evidence, workbook logic, and limits. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Executive Summary | Condenses the dossier thesis, evidence posture, buyer implications, and next-study priorities. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Scope and Evidence Integrity | Defines the evidence window, source boundaries, research-use limits, and labeling discipline. | Lets the buyer audit support strength before relying on the package. |
| Decision Snapshot Overview | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Buy Build Wait Avoid | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Buyer Decision Matrix | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Source Quality Dashboard | Shows how strong the source base is and where conclusions depend on indirect or thinner support. | Lets the buyer audit support strength before relying on the package. |
| The Qualification Ledger Model | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The CoU-QC Classifier | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Current Signal Refresh 2025 2026 | Frames the field's June 2026 state, active programs, research fronts, and timing signals. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Cross Domain Convergence Map | Shows how separate research signals converge, diverge, or interact across domains, mechanisms, or study layers. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Evidence Maturity and Context Matrix | Links claims to source support so users can separate what is known, inferred, and hypothetical. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Comparative Platform Matrix | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Key Findings | Summarizes the most decision-relevant findings and their implications for the dossier thesis. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Anchor gap / adoption order | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Oncology patient-selection (the anchored corner) | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Cardiac safety (anchored to a known liability) | Identifies translational, regulatory, safety, or delivery constraints that shape whether the thesis can be tested. | Shows where the thesis could fail or require more validation before action. |
| Reproducibility metrology (the binding gate) | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Biological completeness (debt, not asset) | Connects research maturity to competitive position, program strategy, and diligence watchpoints. | Connects research claims to practical diligence and monitoring decisions. |
| The validation paradox | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Regulatory channels (named precisely) | Identifies translational, regulatory, safety, or delivery constraints that shape whether the thesis can be tested. | Shows where the thesis could fail or require more validation before action. |
| The first qualification program (metrology-first) | Identifies translational, regulatory, safety, or delivery constraints that shape whether the thesis can be tested. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The coupled digital twin | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| ADME / DDI - tissue-level beats plasma | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| BBB / neuro barrier models | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Immune / microenvironment (the hardest completeness) | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Reproductive / developmental (high need, low qualifiability) | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Vascular / engineering (generic endothelium trap) | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| AI integration (valuable only when coupled) | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The premature-adoption reset hazard | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The substitution frontier by modality | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The qualification method is maturing (recovered) | Identifies translational, regulatory, safety, or delivery constraints that shape whether the thesis can be tested. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The CoU-QC substrate already exists | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The evidentiary floor (recalibrated) | Shows how strong the source base is and where conclusions depend on indirect or thinner support. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Quantitative Evidence | Links claims to source support so users can separate what is known, inferred, and hypothetical. | Lets the buyer audit support strength before relying on the package. |
Evidence & Decision Workbook
The workbook is the decision engine.
A locked public preview of selected workbook-derived sheets: sheet structure, decision modules, power rows, traceability, and audit posture. Licensed buyers receive the full workbook files.
Read-only workbook preview with clipped values and no formulas. Licensed buyers receive the full Evidence & Decision Workbook with editable assumptions and working files.
Workbook inventory
Delivered workbook sheets.
Full inventories belong on dossier pages, not the homepage. Sheet names below are extracted from the actual workbook file.
| # | Workbook sheet | What it does |
|---|---|---|
| 1 | 1. Workbook Guide | Navigation layer for using the workbook, understanding sheet roles, and following the decision package. Public preview exposes Clean claim, Proposes a falsifiable operating. fields and clipped entries such as Source-audit reconciliation, 152 audited = 67. |
| 2 | 2. Claim Ledger | Claim-by-claim ledger showing verdicts, source support, inference status, and decision relevance. Public preview exposes claim_id, claim_text, report_section, report_page fields and clipped entries such as CLM-001, Human retinal organoids supporting.,. |
| 3 | 3. Evidence Table | Evidence-verification surface for checking sources, support quality, and the audit trail. Public preview exposes PMID:42096960, Deciphering spatial-temporal., International immunopharmacology, 2026 fields and clipped entries such as PMID:41794331,. |
| 4 | 4. Source-Support Verdicts | Independent check on whether key claims are actually supported by cited sources. Public preview exposes source_support_verdict, count, definition, release treatment fields and clipped entries such as SUPPORTS_EXACTLY, Source directly supports the claim.,. |
| 5 | 5. Source-Quality Summary | Summary of source strength, gaps, and areas where conclusions depend on weaker evidence. Public preview exposes Metric, Fresh (value-based, this analysis), Superseded (source strict screen) fields and clipped entries such as High-quality primary/review,. |
| 6 | 6. Context Scorecard | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Context-of-use, Human anchor, Reproducibility need, Completeness requirement fields and clipped entries such as Oncology PDO patient-selection,. |
| 7 | 7. CoU-QC Input & Class Output | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Endpoint measurability, specific concordance / functional., 2, 1.1 fields and clipped entries such as Reproducibility, cross-lab / cross-lot CV or. |
| 8 | 8. CoU-QC Decision Rules | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Class label, Strategy, Required next experiment, Intervention fields and clipped entries such as ANCHOR-LIMITED, bootstrap from a human anchor,. |
| 9 | 9. CoU-QC Archetype Cards | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Archetype, Anchor, Endpoint, Reproducibility fields and clipped entries such as Oncology PDO patient-selection, REPRODUCIBILITY-LIMITED, Liver-DILI. |
| 10 | 10. CoU-QC Validation & Panel | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Functional endpoint, Context-specific concordance,. fields and clipped entries such as Comparator baseline, Naive biological-completeness /.,. |
| 11 | 11. Platform - Modality Scoreca | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Platform class, Anchorability, Cross-lab reprod., Completeness fields and clipped entries such as Organ-on-chip / MPS, Moderate, Low-Moderate. |
| 12 | 12. Reproducibility - Metrology | Workbook surface supporting a specific evidence, decision, study-planning, or release-control workflow. Public preview exposes Metrology element, Oncology PDO, Liver-DILI, Cardiac fields and clipped entries such as Cross-lab CV measured, partial, in progress. |
| 13 | 13. Prediction-vs-Qualification | Tracks regulatory, endpoint, reimbursement, or qualification requirements that shape testing strategy. Public preview exposes Cardiac torsade, AUROC >= 0.85 (review-reported)., multi-site cross-lab concordance., no cross-lab data;. fields and clipped entries. |
| 14 | 14. Competitive Landscape | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes company, asset / platform, modality, target / indication fields and clipped entries such as Emulate, Liver-Chip / Organ-Chips, MPS. |
| 15 | 15. Trial - Catalyst Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes NCT, Title, Status, Phase fields and clipped entries such as NCT04859166, Prospective Primary Human Lungcancer., COMPLETED. |
| 16 | 16. Regulatory - Qualification | Tracks regulatory, endpoint, reimbursement, or qualification requirements that shape testing strategy. Public preview exposes Instrument / document, Channel (NAMED precisely), Status (mid-2026), What it does / does NOT do fields and clipped entries such as. |
| 17 | 17. Near-Discovery Watch-List | Monitoring surface for emerging signals, update triggers, and evidence changes that could alter the decision. Public preview exposes Readout / event, Context, When, What it confirms or refutes fields and clipped entries such as First FDA-qualified MPS.,. |
| 18 | 18. Safety - Reset-Hazard Track | Captures failure modes and constraints that could invalidate or narrow a program. Public preview exposes Failure mode, Mechanism, Severity (reset), Where it concentrates fields and clipped entries such as Generic endothelium misses., wrong endothelial. |
| 19 | 19. Figure Source Map | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes figure_id, figure_title, figure_family, section_anchor fields and clipped entries such as fig01_grade_recalibration, Citation re-grade of. |
| 20 | 20. Figure Attempt Ledger | Figure and numeric reproduction log for validating calculations, chart inputs, or displayed values. Public preview exposes Fig #, File, Render status, Visual-QA status (legibility) fields and clipped entries such as fig07_decision_snapshot.png, PASS, PASS. |
| 21 | 21. Hypotheses Ledger | Maps hypotheses to evidence state, falsification logic, endpoints, and next-study design. Public preview exposes #, Tier, Title / axis, Axes coupled fields and clipped entries such as F1, Flagship, The Context-of-Use Qualification.. |
| 22 | 22. Most Valuable Next Studies | Prioritizes next studies that could change the decision, including endpoints and evidence gates. Public preview exposes #, Study, Context, Primary endpoint fields and clipped entries such as Cardiac qualification ring trial, Cardiac, sensitivity/specificity. |
| 23 | 23. Verification & Search Log | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes API / source, query / scope, result / date-status, source_url fields and clipped entries such as Pod clock, ssh date, ubuntu; Mon Jun. |
| 24 | 24. Excluded Claims (85) | Disposition log for rejected, bounded, or quarantined claims so they do not leak into the decision thesis. Public preview exposes #, Disposition, Claim label (excerpt), Reason / salvage fields and clipped entries such as off-topic (below relevance floor),. |
| 25 | 25. Quarantine + Salvage | Disposition log for rejected, bounded, or quarantined claims so they do not leak into the decision thesis. Public preview exposes CN Bio / FDA liver-DILI program, LABELLED., first qualification program;. fields and clipped entries such as Vivodyne $40M. |
| 26 | 26. Power Calculations | Power-calculation layer for assumptions, endpoint logic, computed sample sizes, and sensitivity checks. Public preview exposes hypothesis_id, study_id, endpoint, test_type fields and clipped entries such as F1, MVNS-04, CoU-QC held-out AUC vs fidelity.. |
| 27 | 27. Traceability Certificate | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes claim_id, report_section, report_page, claim_text fields and clipped entries such as CLM-001, see Claim Ledger report_section, section. |
| 28 | 28. Score Basis | Explains how scores or ratings were assigned so the decision instrument can be inspected. Public preview exposes fig04 Diffusion Inversion, anchor (x), adoption (y), novelty., anchor availability + observed. fields and clipped entries such as fig07 Decision. |
| 29 | 29. Version Registry | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes Version, Date, Component, Change / status fields and clipped entries such as v1.0, 2026-06-12, Dossier (report + workbook + 30.. |
| 30 | 30. Audit Issues Log | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes finding_id, audit finding, severity, closure fields and clipped entries such as A4-CLASSIFIER, CoU-QC classifier documented six.,. |
| 31 | 32. Partial Claim Bridges | Workbook surface supporting a specific evidence, decision, study-planning, or release-control workflow. Public preview exposes claim_id, primary_source_id, report_section, evidence_layer fields and clipped entries such as CLM-001, PMID:42119840, Mechanistic. |
| 32 | 31. Release Regression Checks | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes check_id, surface, requirement, status fields and clipped entries such as CACHE-COUQC-B20-B29, 7. CoU-QC Input & Class Output,. |
Power-calculated next studies
Power calculations are the execution bridge.
Power calculations are planning-grade research calculations for endpoint logic, assumptions, sample size, budget, and timeline. They do not prove hypotheses or constitute clinical protocol.
| Hypothesis | Primary endpoint | Test | Effect | α | Power | Computed n | Design n |
|---|---|---|---|---|---|---|---|
| F1 | CoU-QC held-out AUC vs fidelity heuristic | AUC (Hanley-McNeil, external) | 0.8 | 0.05 | 0.80 | 140 | 140 |
| F2 | NAM density by anchor availability score | two-sample means / continuous | 0.25 | 0.05 | 0.80 | 252 | 300 |
| F3 | Cross-lab reproducibility clears concordance gate | two-proportion, pooled | 0.9 | 0.05 | 0.80 | 100 | 120 |
| F4 | Transferred sensitivity by anchor-distance bin | two-proportion, pooled | 0.85 | 0.05 | 0.80 | 73 | 280 |
| F5 | Coupled-twin concordance improvement | two-proportion, pooled | 0.85 | 0.05 | 0.80 | 121 | 140 |
Release audit discipline
Audit posture is part of the product.
Public pages do not publish exact audit scores. They should state the release discipline, revision posture, and limitations without implying peer review or validated clinical guidance.
Research-use decision package
Not medical advice, clinical guidance, investment advice, or a clinical protocol.
Known / inferred / hypothetical
The package separates cited evidence from inference and frontier hypothesis generation.
Audit-gated and revision-controlled
Adversarial audit checks source support, formulas, figures, limitations, and release readiness.
Buy this dossier
Full decision package — 123-page report + 32-sheet workbook
Buy now
- Decision research report (123 pages, PDF)
- Evidence & Decision Workbook (32 sheets, .xlsx) — claims, source-support verdicts, power calculations, traceability, and audit log
- Live, editable power-calculated next studies
$3,500$5,500Launch price